Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Cerebrovascular Disorders

  Free Subscription


Articles published in Circulation

Retrieve available abstracts of 43 articles:
HTML format



Single Articles


    November 2022

  1. Correction to: Early Versus Delayed Non-Vitamin K Antagonist Oral Anticoagulant Therapy After Acute Ischemic Stroke in Atrial Fibrillation (TIMING): A Registry-Based Randomized Controlled Noninferiority Study.
    Circulation. 2022;146:e279.
    PubMed    


  2. BRANDES A, Stavrakis S, Freedman B, Antoniou S, et al
    Consumer-Led Screening for Atrial Fibrillation: Frontier Review of the AF-SCREEN International Collaboration.
    Circulation. 2022;146:1461-1474.
    PubMed     Abstract available


    October 2022
  3. GAZIANO L, Sun L, Arnold M, Bell S, et al
    Mild-to-Moderate Kidney Dysfunction and Cardiovascular Disease: Observational and Mendelian Randomization Analyses.
    Circulation. 2022 Oct 31. doi: 10.1161/CIRCULATIONAHA.122.060700.
    PubMed     Abstract available


    September 2022

  4. Correction to: Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association.
    Circulation. 2022;146:e141.
    PubMed    


  5. OLDGREN J, Asberg S, Hijazi Z, Wester P, et al
    Early Versus Delayed Non-Vitamin K Antagonist Oral Anticoagulant Therapy After Acute Ischemic Stroke in Atrial Fibrillation (TIMING): A Registry-Based Randomized Controlled Noninferiority Study.
    Circulation. 2022 Sep 6:101161CIRCULATIONAHA122060666.
    PubMed     Abstract available


    August 2022
  6. O'DONOGHUE ML, Giugliano RP, Wiviott SD, Atar D, et al
    Long-Term Evolocumab in Patients with Established Atherosclerotic Cardiovascular Disease.
    Circulation. 2022 Aug 29. doi: 10.1161/CIRCULATIONAHA.122.061620.
    PubMed     Abstract available


  7. JURGENS CY, Lee CS, Aycock DM, Masterson Creber R, et al
    State of the Science: The Relevance of Symptoms in Cardiovascular Disease and Research: A Scientific Statement From the American Heart Association.
    Circulation. 2022 Aug 18:101161CIR0000000000001089.
    PubMed     Abstract available


  8. RILLIG A, Borof K, Breithardt G, Camm AJ, et al
    Early Rhythm Control in Patients With Atrial Fibrillation and High Comorbidity Burden.
    Circulation. 2022 Aug 15:101161CIRCULATIONAHA122060274.
    PubMed     Abstract available


    July 2022
  9. KUEHN BM
    Nurse Navigators Cut Stroke Readmissions by Half.
    Circulation. 2022;146:140-141.
    PubMed    


  10. HANKEY GJ
    Endovascular Therapy for Acute Basilar Artery Occlusion.
    Circulation. 2022;146:18-20.
    PubMed    


    June 2022
  11. VAN BELLE E, Debry N, Vincent F, Kuchcinski G, et al
    Cerebral Microbleeds During Transcatheter Aortic Valve Replacement: A Prospective Magnetic Resonance Imaging Cohort.
    Circulation. 2022 Jun 20:101161CIRCULATIONAHA121057145.
    PubMed     Abstract available


  12. HUGUENARD AL, Johnson GW, Osbun JW, Dacey RG, et al
    Frequency of Screening-Detected Intracranial Aneurysms in Patients With Loeys-Dietz Syndrome.
    Circulation. 2022 Jun 17:101161CIRCULATIONAHA122058948.
    PubMed    


  13. ABDEL-QADIR H, Akioyamen LE, Fang J, Pang A, et al
    Association of Neighborhood-Level Material Deprivation With Atrial Fibrillation Care in a Single-Payer Health Care System: A Population-Based Cohort Study.
    Circulation. 2022 Jun 9:101161CIRCULATIONAHA122058949.
    PubMed     Abstract available


  14. TAO C, Qureshi AI, Yin Y, Li J, et al
    Endovascular Treatment Versus Best Medical Management in Acute Basilar Artery Occlusion Strokes: Results From the ATTENTION Multicenter Registry.
    Circulation. 2022 Jun 3:101161CIRCULATIONAHA121058544.
    PubMed     Abstract available


    April 2022
  15. NATALE A, Kar S, Holmes D
    Letter by Natale et al Regarding Article, "Amplatzer Amulet Left Atrial Appendage Occluder Versus Watchman Device for Stroke Prophylaxis (Amulet IDE): A Randomized, Controlled Trial".
    Circulation. 2022;145:e847-e848.
    PubMed    


  16. LAKKIREDDY D, Thaler D, Windecker S
    Response by Lakireddy et al to Letters Regarding Article, "Amplatzer Amulet Left Atrial Appendage Occluder Versus Watchman Device for Stroke Prophylaxis (Amulet IDE): A Randomized, Controlled Trial".
    Circulation. 2022;145:e850-e851.
    PubMed    


  17. PRICE MJ, Gibson DN, Kar S
    Letter by Price et al Regarding the Article, "Amplatzer Amulet Left Atrial Appendage Occluder Versus Watchman Device for Stroke Prophylaxis (Amulet IDE): A Randomized, Controlled Trial".
    Circulation. 2022;145:e849.
    PubMed    


  18. DHRUVA SS, Redberg RF
    Letter by Dhruva and Redberg Regarding Article, "Amplatzer Amulet Left Atrial Appendage Occluder Versus Watchman Device for Stroke Prophylaxis (Amulet IDE): A Randomized, Controlled Trial".
    Circulation. 2022;145:e845-e846.
    PubMed    


  19. VASAN RS, Enserro DM, Xanthakis V, Beiser AS, et al
    Temporal Trends in the Remaining Lifetime Risk of Cardiovascular Disease Among Middle-Aged Adults Across 6 Decades: The Framingham Study.
    Circulation. 2022 Apr 18. doi: 10.1161/CIRCULATIONAHA.121.057889.
    PubMed     Abstract available


    March 2022
  20. JOUNDI RA, Sun JL, Xian Y, Alhanti B, et al
    Association Between Endovascular Therapy Time to Treatment and Outcomes in Patients With Basilar Artery Occlusion.
    Circulation. 2022;145:896-905.
    PubMed     Abstract available


  21. LI KC, Huang L, Tian M, Di Tanna GL, et al
    Cost-effectiveness of a Household Salt Substitution Intervention: Findings From 20,995 Participants of the Salt Substitute and Stroke Study (SSaSS).
    Circulation. 2022 Mar 21. doi: 10.1161/CIRCULATIONAHA.122.059573.
    PubMed     Abstract available


  22. KOWALEWSKI C, Dagres N, Hindricks G
    Are 2 Left Atrial Appendage Guards Better Than 1? The Amulet IDE Randomized Trial.
    Circulation. 2022;145:739-741.
    PubMed    


  23. LUBITZ SA, Atlas SJ, Ashburner JM, Trisini Lipsanopoulos AT, et al
    Screening for Atrial Fibrillation in Older Adults at Primary Care Visits: the VITAL-AF Randomized Controlled Trial.
    Circulation. 2022 Mar 2. doi: 10.1161/CIRCULATIONAHA.121.057014.
    PubMed     Abstract available


    January 2022
  24. TSAO CW, Aday AW, Almarzooq ZI, Alonso A, et al
    Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association.
    Circulation. 2022 Jan 26:CIR0000000000001052. doi: 10.1161/CIR.0000000000001052.
    PubMed     Abstract available


    December 2021
  25. BAHNSON TD, Giczewska A, Mark DB, Russo AM, et al
    Association Between Age and Outcomes of Catheter Ablation Versus Medical Therapy for Atrial Fibrillation: Results from the CABANA Trial.
    Circulation. 2021 Dec 22. doi: 10.1161/CIRCULATIONAHA.121.055297.
    PubMed     Abstract available


  26. ZHENG F, von Spreckelsen N, Hu W
    Letter by Zheng et al Regarding Article, "Efficacy and Safety of Using Dual Versus Monotherapy Antiplatelet Agents in Secondary Stroke Prevention: Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials".
    Circulation. 2021;144:e491-e492.
    PubMed    


  27. TRIFAN G, Gorelick PB, Testai FD
    Response by Trifan et al to Letter Regarding Article, "Efficacy and Safety of Using Dual Versus Monotherapy Antiplatelet Agents in Secondary Stroke Prevention: Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials".
    Circulation. 2021;144:e493-e494.
    PubMed    


    November 2021
  28. HANKEY GJ
    Embolic Stroke of Undetermined Source: Can We Identify Subgroups With High Risk for Atrial Fibrillation Who May Benefit From Oral Anticoagulation?
    Circulation. 2021;144:1747-1749.
    PubMed    


  29. KIRCHHOF P
    In Patients With Recently Diagnosed Atrial Fibrillation, Think Anticoagulation and Rhythm Control.
    Circulation. 2021;144:1587-1589.
    PubMed    


    October 2021
  30. BAHIT MC, Sacco RL, Easton JD, Meyerhoff J, et al
    Predictors of Development of Atrial Fibrillation in Patients With Embolic Stroke Of Undetermined Source: An Analysis of the RE-SPECT ESUS Trial.
    Circulation. 2021 Oct 15. doi: 10.1161/CIRCULATIONAHA.121.055176.
    PubMed     Abstract available


    September 2021
  31. CHO SM, Mehaffey JH, Meyers SL, Cantor RS, et al
    Cerebrovascular Events in Patients With Centrifugal-Flow Left Ventricular Assist Devices: Propensity Score-Matched Analysis From the Intermacs Registry.
    Circulation. 2021;144:763-772.
    PubMed     Abstract available


  32. WITSCH J, Mir SA, Parikh NS, Murthy SB, et al
    Association Between Cervical Artery Dissection and Aortic Dissection.
    Circulation. 2021;144:840-842.
    PubMed    


  33. CHO SM, Mehaffey JH, Meyers SL, Cantor RS, et al
    Cerebrovascular Events in Patients With Centrifugal-Flow Left Ventricular Assist Devices: Propensity Score-Matched Analysis From the Intermacs Registry.
    Circulation. 2021;144:763-772.
    PubMed     Abstract available


    July 2021
  34. RILLIG A, Magnussen C, Ozga AK, Suling A, et al
    Early Rhythm Control Therapy in Patients with Atrial Fibrillation and Heart Failure.
    Circulation. 2021 Jul 30. doi: 10.1161/CIRCULATIONAHA.121.056323.
    PubMed     Abstract available


    May 2021
  35. KUWABARA M, Mori M, Komoto S
    Japanese National Plan for Promotion of Measures Against Cerebrovascular and Cardiovascular Disease.
    Circulation. 2021;143:1929-1931.
    PubMed    


    April 2021
  36. BANGALORE S, Maron DJ, Stone GW, Hochman JS, et al
    Response by Bangalore et al to Letter Regarding Article, "Routine Revascularization Versus Initial Medical Therapy for Stable Ischemic Heart Disease: A Systematic Review and Meta-Analysis of Randomized Trials".
    Circulation. 2021;143:e809-e810.
    PubMed    


    February 2021
  37. BUTALA NM, Makkar R, Secemsky EA, Gallup D, et al
    Cerebral Embolic Protection and Outcomes of Transcatheter Aortic Valve Replacement: Results from the TVT Registry.
    Circulation. 2021 Feb 23. doi: 10.1161/CIRCULATIONAHA.120.052874.
    PubMed     Abstract available


  38. GOFF DC JR, Khan SS, Lloyd-Jones D, Arnett DK, et al
    Bending the Curve in Cardiovascular Disease Mortality: Bethesda + 40 and Beyond.
    Circulation. 2021;143:837-851.
    PubMed     Abstract available


  39. HEMELSOET D, De Keyser J, Van Heuverswyn F, Willems R, et al
    Screening for Fabry Disease in Male Patients With Arrhythmia Requiring a Pacemaker or an Implantable Cardioverter-Defibrillator.
    Circulation. 2021;143:872-874.
    PubMed    


    January 2021
  40. SAADOUN D, Vautier M, Cacoub P
    Medium- and Large-Vessel Vasculitis.
    Circulation. 2021;143:267-282.
    PubMed     Abstract available


    October 2020
  41. AYTEKIN A, Ndrepepa G, Neumann FJ, Menichelli M, et al
    Ticagrelor or Prasugrel in Patients with ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Circulation. 2020 Oct 29. doi: 10.1161/CIRCULATIONAHA.120.050244.
    PubMed     Abstract available


  42. TAMBURINO C, Bleiziffer S, Thiele H, Scholtz S, et al
    Comparison of Self-Expanding Bioprostheses for Transcatheter Aortic Valve Replacement in Patients with Symptomatic Severe Aortic Stenosis: The SCOPE 2 Randomized Clinical Trial.
    Circulation. 2020 Oct 15. doi: 10.1161/CIRCULATIONAHA.120.051547.
    PubMed     Abstract available


  43. DROBNI ZD, Alvi RM, Taron J, Zafar A, et al
    Association Between Immune Checkpoint Inhibitors with Cardiovascular Events and Atherosclerotic Plaque.
    Circulation. 2020 Oct 2. doi: 10.1161/CIRCULATIONAHA.120.049981.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cerebrovascular Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: